Perrigo Company plc To Host Investor Day And To Present At The 32nd Annual J.P. Morgan Healthcare Conference

DUBLIN, Jan. 8, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will hold its Investor Day from 8:00 AM to approximately 12:00 PM EST on February 28, at the New York Stock Exchange located at 11 Wall Street, New York, NY 10005. Due to space limitations, registration is required to attend the event. Requests to register should be sent by e-mail to [email protected] and will be processed in the order in which they are received. To listen to the live webcast, please visit the Investor Relations section of the Perrigo Web site at www.perrigo.com beginning at 8:00 AM. Those attending the webcast should go to the Web site before the meeting to install any necessary software.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

Perrigo also today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the J.P. Morgan Healthcare Conference on Monday, January 13, 2014 at the Westin St. Francis hotel in San Francisco, CA. Interested parties can access the presentation, which is scheduled to begin at 8:00 AM PST. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Perrigo Web site at www.perrigo.com. A replay will be available for 14 days after the event.

From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products and active pharmaceutical ingredients (API), and receives royalties from Multiple Sclerosis drug Tysabri®. The Company is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo's mission is to offer uncompromised "Quality Affordable Healthcare Products™," and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as more than 40 other key markets worldwide, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 28, 2013, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Perrigo